Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Real-World Evidence (RWE) Studies Supported Hematologic Oncology United States Food and Drug Administration (US FDA) Approval: What Do They Look like?

Binglin Yue, Adam Greenbaum, Shaohui Sun, Enda Zhu, Shicheng Weng, Chenmu Du, Xiaojuan Zhang, Shanmei Liao

Blood (2022) 140 (Supplement 1): 13208–13209.

https://doi.org/10.1182/blood-2022-166800

Published: 2022

Journal Articles

Diffuse Large B-Cell Lymphoma Is Infiltrated with Functional CD8 + T-Cells Lacking the Hallmarks of Exhaustion

Adam Greenbaum, MD PhD, Ajay K. Gopal, MD, Jonathan R. Fromm, MD PhD, A McGarry Houghton, MD

Blood (2019) 134 (Supplement_1): 1518.

https://doi.org/10.1182/blood-2019-126217

Published: 2019

Journal Articles

High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials

Manoj P. Menon, MD, Victor A. Chow, MD, Adam Greenbaum, MD PhD, Ryan C. Lynch, MD, Mazyar Shadman, MD MPH, Andrei Shustov, MD, Stephen D. Smith, MD, Brian G. Till, MD, Yolanda D. Tseng, MD, Chaitra S. Ujjani, MD, Thomas S. Uldrick, MD MS, Edus H. Warren, MD PhD, Ajay K. Gopal, MD

Blood (2019) 134 (Supplement_1): 4733.

https://doi.org/10.1182/blood-2019-127505

Published: 2019

Journal Articles

A Pilot Trial of Adriamycin, Pembrolizumab, Vinblastine and Dacarbazine (APVD) for Patients with Untreated Classical Hodgkin Lymphoma

Ryan C. Lynch, MD, Chaitra S. Ujjani, MD, Edus H. Warren, MD PhD, David M. Kurtz, MD PhD, Hilary Coye, PA-C, Jacquelin Vandermeer, BS, Hongyan Du, MD, Adam Greenbaum, MD PhD, Ajay K. Gopal, MD

Blood (2019) 134 (Supplement_1): 5299.

https://doi.org/10.1182/blood-2019-124997

Published: 2019

Journal Articles

Phase II Window Study of Pembrolizumab in Untreated B-Cell Non-Hodgkin Lymphoproliferative Diseases

Ajay K. Gopal, MD, Adam Greenbaum, MD PhD, Ryan C. Lynch, MD, Edus H. Warren, MD PhD, Chaitra S. Ujjani, MD, Mazyar Shadman, MD, Stephen D. Smith, MD, Brian G. Till, MD, Jonathan R. Fromm, MD PhD, Andrei R Shustov, MD, Qian Vicky Wu, PhD, Manoj P. Menon, MD

Blood (2019) 134 (Supplement_1): 5258.

https://doi.org/10.1182/blood-2019-124984

Published: 2019

Journal Articles

CD20 Targeted CAR-T for High-Risk B-Cell Non-Hodgkin Lymphomas

Mazyar Shadman, MD, Ajay K. Gopal, MD, Stephen D. Smith, MD, Ryan C. Lynch, MD, Chaitra S. Ujjani, MD, Cameron J. Turtle, MBBS, PhD, Adam Greenbaum, MD PhD, Mary Redman, Cecilia Yeung, MD, Martina Sersch, MD PhD, Edus H. Warren, MD PhD, David G. Maloney, MD PhD, Brian G. Till, MD

Blood (2019) 134 (Supplement_1): 3235.

https://doi.org/10.1182/blood-2019-125102

Published: 2019

Journal Articles

G-CSF Treatment Induces Toll-Like Receptor Signaling and Regulates Hematopoietic Stem Cell Function

Laura G. Schuettpelz, MD, PhD, Joshua N. Borgerding, Priya Gopalan, MD, PhD, Matt Christopher, MD, PhD, Molly Romine, BS, Jill Woloszynek, Adam Greenbaum, Daniel C. Link, MD

Blood (2013) 122 (21): 1181.

https://doi.org/10.1182/blood.V122.21.1181.1181

Published: 2013

Journal Articles

G-CSF-Induced Alterations in the Bone Marrow Microenvironment Suppress B Lymphopoiesis

Ryan B. Day, Adam Greenbaum, Daniel C. Link

Blood (2012) 120 (21): 1246.

https://doi.org/10.1182/blood.V120.21.1246.1246

Published: 2012

Journal Articles

CXCL12 Production by Early Mesenchymal Progenitors Is Required for Hematopoietic Stem Cell Maintenance

Yen-Michael S. Hsu, MD, PhD, Adam Greenbaum, Laura G. Schuettpelz, MD, PhD, Matthew Christopher, MD, PhD, Joshua N. Borgerding, Ryan B. Day, Takashi Nagasawa, MD, PhD, Daniel C. Link

Blood (2012) 120 (21): 510.

https://doi.org/10.1182/blood.V120.21.510.510

Published: 2012

Journal Articles

N-Cadherin in Osteolineage Cells Is Not Required for Maintenance of Hematopoietic Stem Cells

Adam Greenbaum, Daniel Link, MD

Blood (2011) 118 (21): 2390.

https://doi.org/10.1182/blood.V118.21.2390.2390

Published: 2011

Journal Articles

G-CSF Induces Alterations in the Bone Marrow Microenvironment That Suppress B Lymphopoiesis,

Ryan B Day, Adam Greenbaum, Mahil Rao, Daniel Link, MD

Blood (2011) 118 (21): 3243.

https://doi.org/10.1182/blood.V118.21.3243.3243

Published: 2011

Journal Articles

CXCR2 is the Tpo of the iceberg

Adam Greenbaum, Daniel C. Link

Blood (2011) 117 (16): 4166–4167.

https://doi.org/10.1182/blood-2011-02-332577

Published: 2011

NARROW

Real-World Evidence (RWE) Studies Supported Hematologic Oncology United States Food and Drug Administration (US FDA) Approval: What Do They Look like?

Diffuse Large B-Cell Lymphoma Is Infiltrated with Functional CD8 + T-Cells Lacking the Hallmarks of Exhaustion

High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials

A Pilot Trial of Adriamycin, Pembrolizumab, Vinblastine and Dacarbazine (APVD) for Patients with Untreated Classical Hodgkin Lymphoma

Phase II Window Study of Pembrolizumab in Untreated B-Cell Non-Hodgkin Lymphoproliferative Diseases

CD20 Targeted CAR-T for High-Risk B-Cell Non-Hodgkin Lymphomas

G-CSF Treatment Induces Toll-Like Receptor Signaling and Regulates Hematopoietic Stem Cell Function

G-CSF-Induced Alterations in the Bone Marrow Microenvironment Suppress B Lymphopoiesis

CXCL12 Production by Early Mesenchymal Progenitors Is Required for Hematopoietic Stem Cell Maintenance

N-Cadherin in Osteolineage Cells Is Not Required for Maintenance of Hematopoietic Stem Cells

G-CSF Induces Alterations in the Bone Marrow Microenvironment That Suppress B Lymphopoiesis,

CXCR2 is the Tpo of the iceberg

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only